Skip Navigation Links
ScientificNameLabel
Ixerisoside D
PHCD compound ID : 4041
Chemical Names :
Ixerisoside D
Molecular Formula : C21H28O8
Molecular Weight : 408.178418
More Details :
Names & Synonyms: (3aS,5R,6aR,9aR,9bS)-3,6,9-trimethylene-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one , (3aS,5R,6aR,9aR,9bS)-3,6,9-trimethylene-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one , (3aS,5R,6aR,9aR,9bS)-3,6,9-trimethylidene-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one , (3aS,5R,6aR,9aR,9bS)-5-[(2R,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,6,9-trimethylidene-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one , (3aS,5R,6aR,9aR,9bS)-3,6,9-trimethylene-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one
Smiles: OC[C@H]1O[C@@H](O[C@@H]2C[C@H]3C(=C)C(=O)O[C@@H]3[C@@H]3[C@H](C2=C)CCC3=C)[C@@H]([C@H]([C@@H]1O)O)O
InChi : InChI=1S/C21H28O8/c1-8-4-5-11-9(2)13(6-12-10(3)20(26)29-19(12)15(8)11)27-21-18(25)17(24)16(23)14(7-22)28-21/h11-19,21-25H,1-7H2/t11-,12-,13+,14+,15-,16+,17-,18+,19-,21+/m0/s1
InChi Key : InChIKey=NFPFDUCKBQMYPB-KBPZUBEWSA-N
PubChem ID : 101589321
Rotatable bond count : 3 Rule of five : 0
Hydrogen bond acceptor count : 8 Ionization potential : 9.684457
Hydrogen bond donor count : 4 Electric dipole moment : 6.541
XLogP : -0.054 VDW volume : 382.12228
Molecular weight : 408.178418 HOMO-LUMO gap : 9.522000
Herb list :
Refrences & Litretures:
  
559.      Journal:'Evidence-Based Complementary and Alternative Medicine'      Year:'2013'      Volume:''      Page:'579319'      DOI:'10.1155/2013/579319'      Title:'Cichorium intybus: Traditional Uses, Phytochemistry, Pharmacology, and Toxicology'
Copyright © 2017, Chemistry and Chemical Engineering Research Center of Iran. All rights reserved.
Follow us